Concepts (175)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Platelet Activating Factor | 24 | 2013 | 34 | 4.400 |
Why?
|
| Spermatozoa | 16 | 2021 | 75 | 3.040 |
Why?
|
| Blastocyst | 12 | 2022 | 17 | 1.930 |
Why?
|
| Sperm Motility | 8 | 2015 | 41 | 1.410 |
Why?
|
| Embryonic Development | 6 | 2018 | 100 | 1.400 |
Why?
|
| Platelet Membrane Glycoproteins | 7 | 2003 | 19 | 1.370 |
Why?
|
| Fertilization in Vitro | 10 | 2022 | 47 | 1.250 |
Why?
|
| Receptors, G-Protein-Coupled | 7 | 2003 | 167 | 1.210 |
Why?
|
| Anti-Mullerian Hormone | 5 | 2015 | 6 | 1.160 |
Why?
|
| Infertility, Male | 8 | 2021 | 35 | 1.140 |
Why?
|
| Receptors, Cell Surface | 6 | 2003 | 248 | 1.030 |
Why?
|
| Semen | 6 | 2021 | 29 | 0.670 |
Why?
|
| Cell-Free Nucleic Acids | 1 | 2018 | 11 | 0.630 |
Why?
|
| Sperm Capacitation | 4 | 2007 | 8 | 0.590 |
Why?
|
| Saimiri | 2 | 2012 | 8 | 0.590 |
Why?
|
| Fertility | 4 | 2015 | 60 | 0.550 |
Why?
|
| 1-Alkyl-2-acetylglycerophosphocholine Esterase | 2 | 2006 | 10 | 0.540 |
Why?
|
| Embryo Implantation | 4 | 2018 | 17 | 0.520 |
Why?
|
| Pregnancy | 17 | 2022 | 2334 | 0.500 |
Why?
|
| Embryo, Mammalian | 3 | 2002 | 176 | 0.500 |
Why?
|
| Seasons | 3 | 2012 | 129 | 0.460 |
Why?
|
| Pentoxifylline | 1 | 2013 | 12 | 0.440 |
Why?
|
| Embryonic and Fetal Development | 6 | 1996 | 74 | 0.430 |
Why?
|
| Swine | 3 | 2003 | 672 | 0.430 |
Why?
|
| Preimplantation Diagnosis | 2 | 2022 | 2 | 0.420 |
Why?
|
| Pregnancy Outcome | 3 | 2021 | 157 | 0.420 |
Why?
|
| Embryo Transfer | 3 | 2018 | 18 | 0.410 |
Why?
|
| RNA, Messenger | 5 | 2003 | 1663 | 0.400 |
Why?
|
| Cattle | 4 | 2015 | 475 | 0.380 |
Why?
|
| Macaca mulatta | 2 | 2002 | 76 | 0.370 |
Why?
|
| Sperm Count | 3 | 2015 | 14 | 0.370 |
Why?
|
| Pregnancy Rate | 3 | 2004 | 14 | 0.340 |
Why?
|
| Male | 32 | 2021 | 37283 | 0.330 |
Why?
|
| Animals | 26 | 2015 | 20880 | 0.320 |
Why?
|
| Female | 31 | 2022 | 38021 | 0.320 |
Why?
|
| Primates | 2 | 2005 | 14 | 0.280 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2006 | 24 | 0.280 |
Why?
|
| Insemination, Artificial | 2 | 2021 | 5 | 0.250 |
Why?
|
| Birth Rate | 1 | 2004 | 6 | 0.250 |
Why?
|
| Spinal Cord Injuries | 2 | 2015 | 551 | 0.250 |
Why?
|
| Insemination, Artificial, Homologous | 1 | 2004 | 1 | 0.250 |
Why?
|
| Inhibins | 2 | 2015 | 6 | 0.240 |
Why?
|
| Infertility, Female | 1 | 2004 | 25 | 0.240 |
Why?
|
| Humans | 28 | 2022 | 68549 | 0.240 |
Why?
|
| Oocytes | 3 | 1993 | 57 | 0.220 |
Why?
|
| Intracellular Fluid | 2 | 2000 | 24 | 0.220 |
Why?
|
| Gene Expression | 2 | 2022 | 770 | 0.210 |
Why?
|
| Pregnancy-Associated Plasma Protein-A | 1 | 2022 | 3 | 0.210 |
Why?
|
| Body Mass Index | 1 | 2005 | 866 | 0.210 |
Why?
|
| Chromosome Mapping | 1 | 2002 | 188 | 0.200 |
Why?
|
| Reproductive Health | 1 | 2021 | 6 | 0.200 |
Why?
|
| Zika Virus | 1 | 2021 | 4 | 0.200 |
Why?
|
| Exosomes | 1 | 2021 | 44 | 0.200 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2001 | 110 | 0.180 |
Why?
|
| Mice | 10 | 2006 | 8474 | 0.170 |
Why?
|
| Fluorescent Antibody Technique | 1 | 1999 | 282 | 0.160 |
Why?
|
| Embryo Culture Techniques | 1 | 2018 | 2 | 0.160 |
Why?
|
| Calcium | 2 | 2000 | 929 | 0.160 |
Why?
|
| Cleavage Stage, Ovum | 2 | 1997 | 4 | 0.160 |
Why?
|
| Pre-Eclampsia | 1 | 2000 | 202 | 0.160 |
Why?
|
| Culture Media, Conditioned | 3 | 2022 | 78 | 0.150 |
Why?
|
| Cryopreservation | 1 | 2018 | 103 | 0.150 |
Why?
|
| Caspase 3 | 1 | 2018 | 233 | 0.150 |
Why?
|
| Reference Values | 2 | 2012 | 579 | 0.140 |
Why?
|
| Proteins | 1 | 2000 | 473 | 0.140 |
Why?
|
| Rabbits | 5 | 2000 | 509 | 0.140 |
Why?
|
| Ovarian Follicle | 1 | 1995 | 21 | 0.130 |
Why?
|
| Follicular Fluid | 1 | 1995 | 18 | 0.130 |
Why?
|
| Chorionic Gonadotropin | 1 | 2013 | 7 | 0.120 |
Why?
|
| Polycystic Ovary Syndrome | 1 | 2013 | 13 | 0.120 |
Why?
|
| Antibodies | 1 | 1994 | 241 | 0.110 |
Why?
|
| ROC Curve | 2 | 2006 | 392 | 0.110 |
Why?
|
| Immunoassay | 1 | 2012 | 64 | 0.110 |
Why?
|
| Aneuploidy | 2 | 2022 | 21 | 0.100 |
Why?
|
| Prospective Studies | 5 | 2013 | 3703 | 0.100 |
Why?
|
| Radioimmunoassay | 2 | 2003 | 164 | 0.100 |
Why?
|
| Sex Factors | 2 | 2012 | 1265 | 0.100 |
Why?
|
| Apoptosis | 1 | 2018 | 1641 | 0.100 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2003 | 710 | 0.100 |
Why?
|
| Elephants | 1 | 2010 | 5 | 0.100 |
Why?
|
| Base Sequence | 2 | 2003 | 1015 | 0.090 |
Why?
|
| Puberty | 1 | 2010 | 10 | 0.090 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2006 | 328 | 0.090 |
Why?
|
| Testis | 1 | 2010 | 37 | 0.090 |
Why?
|
| Calibration | 1 | 2010 | 73 | 0.090 |
Why?
|
| Granulosa Cells | 1 | 2010 | 21 | 0.090 |
Why?
|
| Sperm-Ovum Interactions | 3 | 2003 | 7 | 0.090 |
Why?
|
| Molecular Sequence Data | 2 | 2003 | 1446 | 0.090 |
Why?
|
| Protein Multimerization | 1 | 2010 | 71 | 0.090 |
Why?
|
| Species Specificity | 2 | 2001 | 302 | 0.090 |
Why?
|
| Culture Techniques | 2 | 2002 | 65 | 0.090 |
Why?
|
| Adult | 6 | 2015 | 21379 | 0.080 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 507 | 0.080 |
Why?
|
| Regression Analysis | 2 | 2001 | 737 | 0.080 |
Why?
|
| Signal Transduction | 3 | 2005 | 2689 | 0.080 |
Why?
|
| Polymerase Chain Reaction | 2 | 2000 | 492 | 0.080 |
Why?
|
| Sensitivity and Specificity | 1 | 2010 | 1753 | 0.070 |
Why?
|
| Mice, Mutant Strains | 1 | 2006 | 166 | 0.070 |
Why?
|
| Mice, Inbred C57BL | 2 | 2006 | 2791 | 0.060 |
Why?
|
| Linear Models | 1 | 2006 | 521 | 0.060 |
Why?
|
| Flow Cytometry | 1 | 2005 | 489 | 0.060 |
Why?
|
| Exons | 1 | 2003 | 122 | 0.060 |
Why?
|
| Biomarkers | 2 | 2013 | 1593 | 0.060 |
Why?
|
| Ovum | 1 | 2003 | 24 | 0.060 |
Why?
|
| Sequence Analysis, DNA | 1 | 2003 | 208 | 0.050 |
Why?
|
| Endometrium | 1 | 2002 | 31 | 0.050 |
Why?
|
| Insemination | 1 | 2021 | 1 | 0.050 |
Why?
|
| Sequence Homology | 1 | 2001 | 11 | 0.050 |
Why?
|
| Proof of Concept Study | 1 | 2022 | 38 | 0.050 |
Why?
|
| Goats | 1 | 2001 | 17 | 0.050 |
Why?
|
| Chromatography | 1 | 2021 | 47 | 0.050 |
Why?
|
| Organ Specificity | 1 | 2002 | 167 | 0.050 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2021 | 85 | 0.050 |
Why?
|
| Transcription, Genetic | 1 | 2003 | 562 | 0.050 |
Why?
|
| Sequence Alignment | 1 | 2001 | 165 | 0.050 |
Why?
|
| Microscopy, Fluorescence | 2 | 2000 | 261 | 0.050 |
Why?
|
| Epidemics | 1 | 2021 | 12 | 0.050 |
Why?
|
| RNA, Viral | 1 | 2021 | 93 | 0.050 |
Why?
|
| Forecasting | 1 | 2002 | 277 | 0.050 |
Why?
|
| Pregnancy Trimester, Third | 1 | 2000 | 39 | 0.050 |
Why?
|
| Selection, Genetic | 1 | 2001 | 49 | 0.050 |
Why?
|
| RNA | 1 | 2021 | 171 | 0.050 |
Why?
|
| Models, Biological | 1 | 2005 | 981 | 0.050 |
Why?
|
| Osmolar Concentration | 1 | 2000 | 134 | 0.050 |
Why?
|
| Double-Blind Method | 1 | 2004 | 1738 | 0.050 |
Why?
|
| Sperm Head | 1 | 1999 | 2 | 0.040 |
Why?
|
| Sperm Tail | 1 | 1999 | 2 | 0.040 |
Why?
|
| Amino Acid Sequence | 1 | 2001 | 1082 | 0.040 |
Why?
|
| Middle Aged | 3 | 2015 | 21119 | 0.040 |
Why?
|
| Muscle, Skeletal | 1 | 2002 | 396 | 0.040 |
Why?
|
| Obesity | 1 | 2005 | 1074 | 0.040 |
Why?
|
| Treatment Outcome | 2 | 2013 | 7028 | 0.040 |
Why?
|
| Reproduction | 1 | 1998 | 48 | 0.040 |
Why?
|
| Stress, Physiological | 1 | 1999 | 215 | 0.040 |
Why?
|
| Kidney | 1 | 2002 | 945 | 0.040 |
Why?
|
| Lung | 1 | 2002 | 849 | 0.040 |
Why?
|
| Cloning, Molecular | 1 | 1997 | 357 | 0.040 |
Why?
|
| Zona Pellucida | 2 | 1994 | 5 | 0.030 |
Why?
|
| Myocardium | 1 | 2002 | 1204 | 0.030 |
Why?
|
| Coculture Techniques | 1 | 1995 | 147 | 0.030 |
Why?
|
| Culture Media | 1 | 1995 | 155 | 0.030 |
Why?
|
| Organ Culture Techniques | 1 | 1995 | 122 | 0.030 |
Why?
|
| Dairying | 1 | 2015 | 6 | 0.030 |
Why?
|
| Luteinizing Hormone | 1 | 2015 | 31 | 0.030 |
Why?
|
| Follicle Stimulating Hormone | 1 | 2015 | 29 | 0.030 |
Why?
|
| In Vitro Techniques | 1 | 1996 | 765 | 0.030 |
Why?
|
| Horses | 1 | 1994 | 20 | 0.030 |
Why?
|
| Longevity | 1 | 2015 | 59 | 0.030 |
Why?
|
| Testosterone | 1 | 2015 | 96 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 1 | 1995 | 532 | 0.030 |
Why?
|
| Mice, Inbred Strains | 1 | 1994 | 181 | 0.030 |
Why?
|
| Blood Pressure | 1 | 2000 | 1449 | 0.030 |
Why?
|
| Sheep | 1 | 1994 | 128 | 0.030 |
Why?
|
| Acrosome | 1 | 1994 | 1 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2000 | 2265 | 0.030 |
Why?
|
| Lactation | 1 | 2015 | 110 | 0.030 |
Why?
|
| Oogenesis | 1 | 1992 | 10 | 0.030 |
Why?
|
| Cells, Cultured | 2 | 1994 | 2673 | 0.030 |
Why?
|
| Immunoglobulin G | 1 | 1994 | 481 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 2013 | 742 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1995 | 1745 | 0.020 |
Why?
|
| Fertilization | 1 | 1990 | 10 | 0.020 |
Why?
|
| Estrous Cycle | 1 | 2010 | 23 | 0.020 |
Why?
|
| Adolescent | 1 | 2000 | 8904 | 0.020 |
Why?
|
| Age Factors | 1 | 2010 | 1860 | 0.020 |
Why?
|
| Reagent Kits, Diagnostic | 1 | 2005 | 54 | 0.020 |
Why?
|
| Young Adult | 1 | 2015 | 5710 | 0.010 |
Why?
|
| Microinjections | 2 | 1994 | 130 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2005 | 2077 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 1994 | 351 | 0.010 |
Why?
|
| Pronase | 1 | 1992 | 5 | 0.010 |
Why?
|
| Trypsin | 1 | 1992 | 64 | 0.010 |
Why?
|
| Cellular Senescence | 1 | 1992 | 112 | 0.010 |
Why?
|
| Ovulation Induction | 1 | 1990 | 9 | 0.010 |
Why?
|
| Cell Survival | 1 | 1992 | 901 | 0.010 |
Why?
|